GMED logo

GMED

Globus Medical Inc. Class A

$89.70
-$0.98(-1.08%)
59
Overall
60
Value
54
Tech
63
Quality
Market Cap
$11.98B
Volume
858.00K
52W Range
$51.79 - $101.40
Target Price
$105.33

Company Overview

Mkt Cap$11.98BPrice$89.70
Volume858.00KChange-1.08%
P/E Ratio116.3Open$90.13
Revenue$2.5BPrev Close$90.68
Net Income$103.0M52W Range$51.79 - $101.40
Div YieldN/ATarget$105.33
Overall59Value60
Quality63Technical54

No chart data available

About Globus Medical Inc. Class A

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Sector: Healthcare
Industry: Medical Devices

Latest News

RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED)

In a report released on January 7, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Globus Medical, with a price target of $100.00. ...

TipRanks Auto-Generated Intelligence Newsdeska month ago

Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)

TipRanks Auto-Generated Intelligence Newsdeska month ago

Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Globus Medical (GMED)

Christine Browna month ago

Barclays Keeps Their Buy Rating on Globus Medical (GMED)

TipRanks Auto-Generated Intelligence Newsdeska month ago

Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Verrica Pharmaceuticals (VRCA)

Howard Kima month ago
ABCD
1SymbolPriceChangeVol
2GMED$89.70-1.1%858.00K
3
4
5
6

Get Globus Medical Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.